Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-01 Jacobs Bruce N. Chief Financial Officer Grant or award +13,300 40,814
2022-03-01 Jacobs Bruce N. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2022-03-01 Gollob Jared Chief Medical Officer Grant or award +12,600 37,257
2022-03-01 Gollob Jared Chief Medical Officer Grant or award · Stock Option (Right to Buy) −75,800 75,800
2022-03-01 Caughey Elaine Chief Business Officer Grant or award +7,000 7,000
2022-03-01 Caughey Elaine Chief Business Officer Grant or award · Stock Option (Right to Buy) +41,000 41,000
2022-01-31 BVF PARTNERS L P/IL Director Purchase +20,085 $40.70 $817K 1,900,272
2022-01-31 BVF PARTNERS L P/IL Director Purchase +14,323 $40.70 $583K 1,395,925
2022-01-27 BVF PARTNERS L P/IL Director Purchase +58,042 $38.33 $2.2M 1,880,187
2022-01-27 BVF PARTNERS L P/IL Director Purchase +37,859 $38.33 $1.5M 1,381,602
2022-01-24 BVF PARTNERS L P/IL Director Purchase +158,041 $37.76 $6.0M 1,822,145
2022-01-24 BVF PARTNERS L P/IL Director Purchase +114,726 $37.76 $4.3M 1,343,743
2022-01-18 MARAGANORE JOHN Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2022-01-14 Mainolfi Nello Chief Executive Officer Exercise or conversion +10,000 $2.08 $21K 482,199
2022-01-14 Mainolfi Nello Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 66,424
2022-01-14 Jacobs Bruce N. Chief Financial Officer Exercise or conversion +10,000 $2.08 $21K 27,514
2022-01-14 Jacobs Bruce N. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 179,899
2022-01-12 Jacobs Bruce N. Chief Financial Officer Exercise or conversion +15,000 $2.08 $31K 32,514
2022-01-12 Jacobs Bruce N. Chief Financial Officer Sale −6,427 $51.21 $329K 26,087
2022-01-12 Jacobs Bruce N. Chief Financial Officer Sale −7,151 $52.13 $373K 18,936

Page 39 of 41 · 810 trades